Type 2 diabetes occurs when the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood sugar levels. Medications aim to lower blood glucose, reduce A1C, and ...
SELECT was a large study focused on obesity and cardiovascular disease in people without type 2 diabetes, but it included kidney outcomes as a secondary end point. The data showed that semaglutide ...
Pharma regulations in China, India, Turkey, and elsewhere mean that Novo Nordisk’s patent on the drug expires this week.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results